Free Trial

Ardelyx (ARDX) Competitors

Ardelyx logo
$4.82 +0.22 (+4.78%)
Closing price 04:00 PM Eastern
Extended Trading
$4.86 +0.04 (+0.81%)
As of 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ARDX vs. ELAN, PCVX, RYTM, PTCT, ZLAB, ACLX, RARE, RNA, AKRO, and MRUS

Should you be buying Ardelyx stock or one of its competitors? The main competitors of Ardelyx include Elanco Animal Health (ELAN), Vaxcyte (PCVX), Rhythm Pharmaceuticals (RYTM), PTC Therapeutics (PTCT), Zai Lab (ZLAB), Arcellx (ACLX), Ultragenyx Pharmaceutical (RARE), Avidity Biosciences (RNA), Akero Therapeutics (AKRO), and Merus (MRUS). These companies are all part of the "pharmaceutical products" industry.

Ardelyx vs.

Ardelyx (NASDAQ:ARDX) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk, media sentiment and community ranking.

58.9% of Ardelyx shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 5.9% of Ardelyx shares are held by company insiders. Comparatively, 0.6% of Elanco Animal Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Elanco Animal Health had 6 more articles in the media than Ardelyx. MarketBeat recorded 14 mentions for Elanco Animal Health and 8 mentions for Ardelyx. Ardelyx's average media sentiment score of 0.89 beat Elanco Animal Health's score of 0.50 indicating that Ardelyx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ardelyx
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elanco Animal Health
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Neutral

Ardelyx has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500.

Ardelyx has higher earnings, but lower revenue than Elanco Animal Health. Ardelyx is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ardelyx$333.62M3.41-$39.14M-$0.16-29.84
Elanco Animal Health$4.44B0.93-$1.23B$0.6712.41

Elanco Animal Health has a net margin of 4.60% compared to Ardelyx's net margin of -11.73%. Elanco Animal Health's return on equity of 6.78% beat Ardelyx's return on equity.

Company Net Margins Return on Equity Return on Assets
Ardelyx-11.73% -24.87% -10.51%
Elanco Animal Health 4.60%6.78%3.03%

Ardelyx currently has a consensus target price of $10.61, suggesting a potential upside of 122.22%. Elanco Animal Health has a consensus target price of $14.67, suggesting a potential upside of 76.39%. Given Ardelyx's stronger consensus rating and higher possible upside, research analysts plainly believe Ardelyx is more favorable than Elanco Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ardelyx
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00
Elanco Animal Health
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

Ardelyx received 395 more outperform votes than Elanco Animal Health when rated by MarketBeat users. Likewise, 67.46% of users gave Ardelyx an outperform vote while only 54.62% of users gave Elanco Animal Health an outperform vote.

CompanyUnderperformOutperform
ArdelyxOutperform Votes
537
67.46%
Underperform Votes
259
32.54%
Elanco Animal HealthOutperform Votes
142
54.62%
Underperform Votes
118
45.38%

Summary

Ardelyx beats Elanco Animal Health on 10 of the 19 factors compared between the two stocks.

Remove Ads
Get Ardelyx News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARDX vs. The Competition

MetricArdelyxPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.10B$6.27B$5.29B$7.35B
Dividend YieldN/A3.24%5.11%4.32%
P/E Ratio-28.756.6921.6917.68
Price / Sales3.29222.71373.9692.89
Price / CashN/A65.6738.1534.64
Price / Book6.305.776.363.94
Net Income-$39.14M$142.01M$3.20B$247.45M
7 Day Performance8.24%5.79%3.96%3.17%
1 Month Performance-15.13%-15.47%-10.34%-8.53%
1 Year Performance-29.77%-10.99%10.38%0.32%

Ardelyx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARDX
Ardelyx
4.2459 of 5 stars
$4.82
+4.8%
$10.61
+120.1%
-31.4%$1.15B$333.62M-30.1390Analyst Revision
News Coverage
ELAN
Elanco Animal Health
4.3479 of 5 stars
$8.69
+0.8%
$14.67
+68.8%
-40.3%$4.31B$4.44B21.739,800Analyst Forecast
PCVX
Vaxcyte
3.2719 of 5 stars
$32.04
+2.7%
$136.50
+326.0%
-53.2%$4.13BN/A-6.97160Positive News
RYTM
Rhythm Pharmaceuticals
3.8274 of 5 stars
$60.14
+1.0%
$74.92
+24.6%
+59.2%$3.80B$130.13M-13.89140Analyst Revision
PTCT
PTC Therapeutics
3.8944 of 5 stars
$45.08
+4.9%
$63.77
+41.5%
+83.5%$3.56B$806.78M-7.591,410Upcoming Earnings
Short Interest ↑
Positive News
ZLAB
Zai Lab
2.8645 of 5 stars
$31.52
+6.7%
$47.37
+50.3%
+100.6%$3.46B$398.99M-11.381,950Gap Up
High Trading Volume
ACLX
Arcellx
2.013 of 5 stars
$60.30
+1.9%
$110.67
+83.5%
+9.9%$3.31B$107.94M-84.9380Positive News
RARE
Ultragenyx Pharmaceutical
4.5074 of 5 stars
$34.92
+2.3%
$92.79
+165.7%
-17.3%$3.28B$560.23M-5.511,310Analyst Revision
Positive News
RNA
Avidity Biosciences
1.966 of 5 stars
$26.91
+5.2%
$66.69
+147.8%
+7.7%$3.23B$10.90M-9.34190
AKRO
Akero Therapeutics
4.2114 of 5 stars
$37.60
+5.4%
$76.29
+102.9%
+71.8%$2.99BN/A-10.0330Insider Trade
MRUS
Merus
2.9564 of 5 stars
$42.43
+1.1%
$85.31
+101.1%
+4.0%$2.93B$36.13M-10.7437Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:ARDX) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners